Oliver Demaine
Oliver is an Analyst in our Business Services team.
His chief responsibilities include producing detailed analysis of transaction trends in a variety of sectors and to provide bespoke research to support business development and deal delivery.
Before joining Alantra, he worked at JM Finn and has past experience at Odey Asset Management and Stifel Nicolaus.
Oliver graduated with First Class Honours in Economics from the University of Exeter.
Outside of work, Oliver is a keen sailor and rugby player.
Alantra expands its technology sector team with two senior appointments
Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.
Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital
We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.
Alantra strengthens its pharma sector focus with senior appointment
Alantra has appointed Anthony Harrington as a partner and key member of its healthcare advisory team. A leading advisor to the pharma services sector, Anthony has over 15 years of M&A experience in the healthcare sector.
Alantra advises Maine Pointe on its partnership with SGS
Alantra advises US-based Maine Pointe on its international investment by SGS, the Swiss-listed, global testing, inspection and certification specialist.
Alantra advises ECI on its investment in Send For Help
Alantra has advised ECI on its investment in Send For Help, the global leading provider of lone worker protection.